Guidelines for Using OxyContin (Oxycodone) for Moderate to Severe Pain Management
Oxycodone (OxyContin) is recommended as a second-line treatment for moderate to severe pain when non-opioid analgesics have failed or are contraindicated, and should be prescribed at the lowest effective dose for the shortest duration possible to minimize risks of addiction, abuse, and misuse. 1
Patient Selection and Initial Assessment
Pain severity should be assessed using validated tools such as:
- Visual Analogue Scales (VAS)
- Verbal Rating Scale (VRS)
- Numerical Rating Scale (NRS) 2
OxyContin is indicated only for patients:
- With pain severe enough to require an opioid analgesic
- For whom alternative treatments are inadequate
- When non-opioid analgesics have not been tolerated or have not provided adequate analgesia 1
Treatment Algorithm
Step 1: Non-opioid Analgesics (Mild Pain - WHO Level I)
- First try paracetamol/acetaminophen and/or NSAIDs 2
- Maximum daily doses:
- Acetaminophen: 4000 mg/day
- Ibuprofen: 2400 mg/day
- Naproxen: 1000 mg/day 2
Step 2: Weak Opioids or Low-Dose Strong Opioids (Moderate Pain - WHO Level II)
- If pain persists, consider:
Step 3: Strong Opioids (Severe Pain - WHO Level III)
- For moderate to severe pain unresponsive to previous steps:
OxyContin Dosing Guidelines
Initial Dosing
- Starting dose: 5-15 mg every 4-6 hours as needed for pain 1
- For opioid-naïve patients: Start with immediate-release formulation before transitioning to controlled-release 3
- For chronic pain: Administer on a regular schedule (every 12 hours for controlled-release) rather than as needed 1
Dose Titration
- Individually titrate to a dose that provides adequate analgesia with minimal side effects 1
- Monitor closely for respiratory depression, especially within the first 24-72 hours and following dose increases 1
- For patients with chronic pain requiring stable dosing, controlled-release formulations can be titrated as effectively as immediate-release formulations 3
Maintenance Therapy
- Once stable pain control is achieved, maintain the effective dose on a regular schedule 1
- Provide breakthrough pain medication (immediate-release oxycodone) at approximately 10% of the total daily dose 2
- If more than 4 breakthrough doses per day are needed, increase the baseline controlled-release dose 2
Special Populations and Considerations
Renal Impairment
- Use with caution and at reduced doses and frequency in patients with renal impairment 2
- Fentanyl and buprenorphine are safer alternatives for patients with chronic kidney disease stages 4-5 2
Elderly Patients
- Start at lower doses and titrate more slowly
- Monitor more frequently for side effects 4
Management of Side Effects
Constipation
- Laxatives must be routinely prescribed for both prophylaxis and management of opioid-induced constipation 2
Nausea/Vomiting
- Metoclopramide and antidopaminergic drugs should be used for treatment of opioid-related nausea/vomiting 2
Other Common Side Effects
- Monitor for somnolence, dizziness, and pruritus
- These side effects often diminish after the first few days of therapy 3
Monitoring and Follow-up
- Regular assessment of pain control and side effects
- Evaluate for signs of misuse, abuse, or addiction
- Document pain scores, functional improvement, and side effects at each visit
- Consider opioid rotation if inadequate analgesia or intolerable side effects occur despite dose optimization 2
Important Cautions
- OxyContin has significant potential for abuse and diversion, particularly in rural areas 5
- High-dose oxycodone (>150 mg/day) should be reserved for cancer pain management when lower doses are ineffective 6
- Avoid combining with other CNS depressants when possible
- For cancer pain, consider adjuvant medications (gabapentin, pregabalin) for enhanced analgesia 6
By following these guidelines, clinicians can appropriately prescribe OxyContin for moderate to severe pain while minimizing risks and optimizing pain control and quality of life for patients.